CeriBell, Inc. (CBLL) vs Integra LifeSciences Holdings Corporation (IART)
A side-by-side comparison of CeriBell, Inc. and Integra LifeSciences Holdings Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CBLL
CeriBell, Inc.
$24.70HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
IART
Integra LifeSciences Holdings Corporation
$12.97HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT
Total return — CBLL vs IART
growth of $100 · dividends reinvested · last 2yCBLL -0.6% (-0.3%/yr)IART -26.6% (-14.3%/yr)CBLL compounded faster over this window
CBLL IART
CBLL vs IART: by the numbers
- •IART is the larger company ($1.01B vs $937M market cap).
- •Both run net losses; IART's is the smaller (-0.44% vs -64.73% net margin).
Metrics side by side
Valuation
| Metric | CBLL | IART |
|---|---|---|
| Forward P/E | N/A | 5.32 |
| P/S ratio | 9.19 | 0.61 |
| P/B ratio | 7.30 | 0.96 |
| EV / EBITDA | N/A | 3.50 |
Profitability
| Metric | CBLL | IART |
|---|---|---|
| Gross margin | 88.90% | 53.74% |
| Operating margin | -68.62% | 4.18% |
| Net margin | -64.73% | -0.44% |
| ROE | -51.43% | -0.69% |
| ROIC | -46.54% | 20.01% |
Growth (annualized)
| Metric | CBLL | IART |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 1.77% |
| Total return CAGR (5Y) | N/A | -28.16% |
Go deeper
Dig into the metrics
CeriBell ROEIntegra LifeSciences ROECeriBell operating marginIntegra LifeSciences operating marginCeriBell revenue growthIntegra LifeSciences revenue growthCeriBell free cash flowIntegra LifeSciences free cash flow
CeriBell & Integra LifeSciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.